Risk factors predicting Candida infective endocarditis in patients with candidemia

Author:

Foong Kap Sum1ORCID,Sung Abby2,Burnham Jason P3ORCID,Kronen Ryan2,Lian Qinghua4,Salazar Zetina Ana2,Hsueh Kevin3,Lin Charlotte2,Powderly William G3,Spec Andrej3ORCID

Affiliation:

1. Section of Infectious Diseases, University of Illinois College of Medicine at Peoria, Peoria, Illinois, USA

2. Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA

3. Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri, USA

4. Washington University School of Medicine, St Louis, Missouri, USA

Abstract

Abstract Candida infective endocarditis (CIE) is a rare but serious complication of candidemia. Incidence and risk factors associated with CIE among candidemic patients are poorly defined from small cohorts. Identification of clinical predictors associated with this entity may guide more judicious use of cardiac imaging. We conducted a retrospective analysis of all inpatients aged ≥18 years diagnosed with candidemia at our institution. CIE was diagnosed by fulfilling two of the major Duke criteria: specifically a vegetation(s) on echocardiogram and positive blood cultures for Candida spp. We used univariable and multivariable regression analyses to identify risk factors associated with CIE. Of 1,873 patients with candidemia, 47 (2.5%) were identified to have CIE. In our multivariable logistic model, existing valvular heart disease was associated with a higher risk for CIE (adjusted odds ratio [aOR], 7.66; 95% confidence interval [CI], 2.95–19.84). Predictors that demonstrated a decreased risk of CIE included infection with C. glabrata (aOR, 0.17; 95% CI, 0.04–0.69), hematologic malignancy (aOR, 0.09; 95% CI, 0.01–0.68), and receipt of total parenteral nutrition (aOR, 0.38; 95% CI, 0.16–0.91). The 90-day crude mortality for CIE was 48.9%, similar to the overall non-CIE mortality of 41.9% (P = .338). We identified a set of clinical factors that can predict the presence of CIE among patient with candidemia. These findings may reduce the need for unnecessary expensive and invasive imaging studies in a subset of patients with a lower risk profile for endocarditis and alternative infection source.

Funder

Astellas Pharma Global Development

Washington University Institute of Clinical and Translational Sciences

National Center for Advancing Translational Sciences

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine

Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Embolic stroke and misidentification candida species endocarditis: Case presentation and literature review;Diagnostic Microbiology and Infectious Disease;2024-02

2. Infections fongiques en réanimation;Anesthésie & Réanimation;2024-02

3. Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management;Clinical Microbiology Reviews;2023-09-21

4. Endocarditis in critically ill patients: a review;Current Opinion in Critical Care;2023-08-30

5. Invasive fungal infections in liver diseases;Hepatology Communications;2023-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3